https://en.bioecon.ru/companies/tempus-ai/Recent content in Tempus-Ai on BioeconHugoen-USMon, 20 Jul 2026 17:49:19 +0700https://en.bioecon.ru/technology/multi-omics-diagnostic-panels-precision-oncology/Mon, 20 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/multi-omics-diagnostic-panels-precision-oncology/Integrative genomic, transcriptomic and proteomic oncology profiling platforms that combine multiple molecular data layers into a single treatment-matching report, broader than a single drug-label companion diagnostic: Tempus AI and Caris Life Sciences in the US, Sophia Genetics in Switzerland, Geneseeq Technology in China, and 1cell.ai in India.https://en.bioecon.ru/technology/personalized-diagnostics/Thu, 25 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/personalized-diagnostics/Molecular diagnostics leveraging NGS, liquid biopsy, and AI for precision medicine and targeted therapies.https://en.bioecon.ru/technology/bioinformatics-multi-omics/Mon, 22 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/bioinformatics-multi-omics/Sequencing, single-cell and spatial omics, and biological AI that turn raw reads into decisions — a stack from sample to interpreted multi-omics.